Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP235840.RAIw7Rw7P2b5vIH2EwkqDbHzP9o14nc9r4EPOQgR2glQY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP235840.RAIw7Rw7P2b5vIH2EwkqDbHzP9o14nc9r4EPOQgR2glQY130_assertion type Assertion NP235840.RAIw7Rw7P2b5vIH2EwkqDbHzP9o14nc9r4EPOQgR2glQY130_head.
- NP235840.RAIw7Rw7P2b5vIH2EwkqDbHzP9o14nc9r4EPOQgR2glQY130_assertion description "[The predicted median in-field local control was significantly longer for EGFR-mutant and ALK-translocated tumors compared with other patients with NSCLC (P < 0.001), whereas distant brain recurrence time was equivalent (P = 0.97).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235840.RAIw7Rw7P2b5vIH2EwkqDbHzP9o14nc9r4EPOQgR2glQY130_provenance.
- NP235840.RAIw7Rw7P2b5vIH2EwkqDbHzP9o14nc9r4EPOQgR2glQY130_assertion evidence source_evidence_literature NP235840.RAIw7Rw7P2b5vIH2EwkqDbHzP9o14nc9r4EPOQgR2glQY130_provenance.
- NP235840.RAIw7Rw7P2b5vIH2EwkqDbHzP9o14nc9r4EPOQgR2glQY130_assertion SIO_000772 23897899 NP235840.RAIw7Rw7P2b5vIH2EwkqDbHzP9o14nc9r4EPOQgR2glQY130_provenance.
- NP235840.RAIw7Rw7P2b5vIH2EwkqDbHzP9o14nc9r4EPOQgR2glQY130_assertion wasDerivedFrom befree-20150227 NP235840.RAIw7Rw7P2b5vIH2EwkqDbHzP9o14nc9r4EPOQgR2glQY130_provenance.
- NP235840.RAIw7Rw7P2b5vIH2EwkqDbHzP9o14nc9r4EPOQgR2glQY130_assertion wasGeneratedBy ECO_0000203 NP235840.RAIw7Rw7P2b5vIH2EwkqDbHzP9o14nc9r4EPOQgR2glQY130_provenance.